Related Experiment Videos

Serum copper in myocardial infarction--diagnostic and prognostic significance

Angiology
|August 1, 1985
PubMed

Insights

Serum copper levels significantly increase in acute myocardial infarction patients, peaking on day 7. Elevated copper may aid in diagnosing and predicting outcomes for myocardial infarction.

Area of Science:

  • Cardiology
  • Clinical Biochemistry

Background:

  • Serum copper is an essential trace element involved in various physiological processes.
  • Changes in serum copper levels have been investigated as potential biomarkers for cardiovascular diseases.

Purpose of the Study:

  • To investigate the diagnostic and prognostic significance of serum copper levels in acute myocardial infarction (AMI).
  • To compare serum copper levels in AMI patients, angina patients, and healthy controls.

Main Methods:

  • Serum copper levels were measured in 44 AMI patients, 23 angina patients, and 40 healthy controls.
  • Serial measurements were taken to observe changes over 28 days.
  • Correlations with cardiac enzyme levels (creatinine phosphokinase and lactic dehydrogenase) were analyzed.

Main Results:

  • Serum copper levels were significantly higher in AMI patients compared to angina patients and controls.
  • A distinct pattern of rise and fall was observed, peaking on the 7th day post-AMI.
  • Complicated AMI cases showed higher serum copper levels, especially on day 28, and significantly higher mean peak levels compared to uncomplicated cases.
  • Serial serum copper changes correlated significantly with creatinine phosphokinase and lactic dehydrogenase levels.

Conclusions:

  • Serum copper is a valuable biochemical marker for diagnosing acute myocardial infarction.
  • The dynamic changes and peak levels of serum copper may offer prognostic insights into AMI outcomes.
  • Further research into serum copper's role in cardiovascular disease management is warranted.

Related Concept Videos